Citing an increase in safety events and evidence of futility, the U.S. NIH stopped an investigational low-dose rivaroxaban arm of its Comparison of Anticoagulation and Antiplatelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) trial. …

… a treatment arm of Bayer and Johnson & Johnson’s Xarelto (rivaroxaban … ) in a phase 3 stroke prevention trial … Taro Pharmaceuticals gained the first FDA approvals … That said, the drug';s fourth- …

… 1. Certain Statins Certain statins and grapefruit do … containing medications, such as hormonal contraceptive pills or … (clopidogrel) Xarelto (rivaroxaban) 11. Some Cancer Medications Grapefruit can … breaks down these medications. High drug levels can lead …

… blood thinner Xarelto toppled from the cliff last year, Bayer forecasted … drug Nubeqa. The androgen receptor inhibitor notched its first FDA … a woman and her doctor decide it’s the … the biotech Medera to develop a congestive heart failure treatment, and …

… drugs Seniors with a Medicare Part D plan for prescription drug … Farxiga Enbrel Jardiance Stelara Xarelto Eliquis Entresto Imbruvica The … the diagnosis, evaluation, or treatment of symptoms of an … the diagnosis, evaluation, or treatment of a mental and…

… in a late-stage trial, bolstering its prospects of … sales for the drug. The drug is part of Bayer's … sellers including blood thinner Xarelto and eye medicine Eylea. Asundexian previously … , but Bayer saw blockbuster potential as a stroke treatment. About …

… for those treatments is increasing, including medicines for … medicines in Medicare Part D (i.e., self-administered drugs such as pills … Stelara, and Xarelto from the selected drugs list effective … 17] There are multiple FDA approved biosimilars to Stelara. …

… 14 deals with pharmaceutical manufacturers through what … their catalogs. The medicines include treatments for: Diabetes Rheumatoid … FDA, will follow that pricing plan. A Wegovy pill … autoimmune diseases. Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, …

… class action concerning Bayer’s anticoagulant (blood thinning) drug Xarelto, which is alleged …